Use of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases

Terapevticheskii Arkhiv

Volumn 82, Issue 2, 2010, Pages 38-43

  Lazebnik, L B ^a   Konoplyannikov, A G ^b   Knyazev, O V ^a   Parfenov, A I ^a   Tsaregorodtseva, T M ^a   Ruchkina, I N ^a   Khomeriki, S G ^a   Rogozina, V A ^a   Konoplyannikova, O A ^b  

^a Central Research Institute of Gastroenterology   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Allogeneic mesenchymal stem cells; Crohn's disease; Ulcerative colitis

Indexed keywords

ADULT; ALLOTRANSPLANTATION; ARTICLE; BIOPSY; CELL CULTURE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CROHN DISEASE; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HUMAN; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; BIOPSY; CELLS, CULTURED; COLITIS, ULCERATIVE; CROHN DISEASE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; INJECTIONS, INTRAVENOUS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950229819     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Fiocchi C. The multifactorial pathogenesis of IBD. Jn: Inflammatory bowel disease -diagnostic and therapeutic strategies: Falk symposium 154. June 9-10. Abstracts. 2006: 21-22.
2. Frieedenstein A. J., Petrakova K. V., Kurolesova A. L., Frolova G. P. Hetrotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoetic tissue. Transplantation 1968; 6 (2): 230-247.
3. Dennis J., Charbord P. Origin and differentiation of human and murine stroma stem. Cells 2002; 20: 205-214.
4. Stasi R., Provan D. Management of immune thrombocytopenic purpura in adults. Mayo Clin. Proc. 2004; 79 (4): 504-522.
5. Aggarwal S., Pittinger M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105 (4): 1815-1822.
6. Makino S., Fukuda K., Miρshi S. et al. Cardiomyocytes can be regeneration from marrow stromal cells in vitro. J. Clin. Invest. 1999; 103: 697-705.
7. Caplan A. I., Heckman J. D., Lennon D. P. et al. Osteochondral progenitor cells in acute and chronic canine nonunions. J. Orthop. Res. 1999; 17: 240-255.
8. Tyndall A., Matucci-Cerinic M. Haematopoietic stem cell transplantation for the treatment of systemic sclerosis and other autoimmune disorders. Expert Opin. Biol. Ther. 2003; 3 (7): 1040-1049.
9. Jayne D., Passweg J., Marmont A. et al. Autologous stem cell transplantation for systsmic lupus erythematosus. Lupus 2004; 13 (3): 168-176.
10. Chaudhari M., Cornelis J. G., Schatz D. et al. Pancreatic stem cells: a therapeutic agent that may offer the best approach for curing type 1 diabetes. Pediatr Diabet. 2001; 2 (4): 195-202.
11. Yamaoka T. Regeneration therapy of pancreatic beta cells: towards a cure for diabetes? Biochem. Biophys. Res. Commun. 2002; 296 (5): 1039-1043.
12. Banias G., Sugawara K., Pagninl C., Cominelli F. The Thl immune pathway as a the: apeutic target in Crohn's disease. Cuir. Opin. Invest. Drugs 2003; 4: 1279-1286.
13. 2 lencinerich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
14. Oyama Y., Craig R. M., Traynor A. E. et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 2005; 128 (3): 552-563.
15. Hawkey C. J. Stem cell transplantation for Crohn's disease. Best Pract. Res. Clin. Haematol. 2004; 17 (2): 317-325.
16. Geboes K., Riddel R., Eensfelt B. et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000; 47: 404-409.